Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 26 articles: HTML format

Single Articles

February 2021
1. DEBERGE M, Glinton K, Subramanian M, Wilsbacher LD, et al
   Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
   J Clin Invest. 2021 Feb 2. pii: 139576. doi: 10.1172/JCI139576.
   PubMed     Abstract available
   
   
   May 2020
2. NAH J, Zhai P, Huang CY, Fernandez AF, et al
   Upregulation of Rubicon promotes autosis during myocardial ischemia/reperfusion injury.
   J Clin Invest. 2020 May 4. pii: 132366. doi: 10.1172/JCI132366.
   PubMed     Abstract available
   
   
   March 2020
3. SIRAJ MA, Mundil D, Beca S, Momen A, et al
   Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-alpha.
   J Clin Invest. 2020;130:1392-1404.
   PubMed     Abstract available
   
   
   January 2020
4. LEUCKER TM, Schulman SP, Gerstenblith G
   Stable ischemic heart disease: how to keep it that way.
   J Clin Invest. 2020 Jan 27. pii: 135959. doi: 10.1172/JCI135959.
   PubMed    
   
   
   
5. ECHOUFFO-TCHEUGUI JB, Jain M, Cheng S
   Breaking through the surface: more to learn about lipids and cardiovascular disease.
   J Clin Invest. 2020 Jan 27. pii: 134696. doi: 10.1172/JCI134696.
   PubMed     Abstract available
   
   
   
6. LEOPOLD JA, Maron BA, Loscalzo J
   The application of big data to cardiovascular disease: paths to precision medicine.
   J Clin Invest. 2020;130:29-38.
   PubMed     Abstract available
   
   
   
7. JAIN M, Dhanesha N, Doddapattar P, Chorawala MR, et al
   Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia.
   J Clin Invest. 2020;130:295-314.
   PubMed     Abstract available
   
   
   
8. MASOUD AG, Lin J, Azad AK, Farhan MA, et al
   Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury.
   J Clin Invest. 2020;130:94-107.
   PubMed     Abstract available
   
   
   December 2019
9. MCCLENAGHAN C, Huang Y, Yan Z, Harter T, et al
   Glibenclamide reverses cardiovascular abnormalities of Cantu Syndrome driven by KATP channel overactivity.
   J Clin Invest. 2019 Dec 10. pii: 130571. doi: 10.1172/JCI130571.
   PubMed     Abstract available
   
   
   November 2019
10. POSS AM, Maschek JA, Cox JE, Hauner BJ, et al
    Machine Learning Reveals Serum Sphingolipids as Cholesterol-Independent Biomarkers of Coronary Artery Disease.
    J Clin Invest. 2019 Nov 19. pii: 131838. doi: 10.1172/JCI131838.
    PubMed     Abstract available
    
    
    August 2019
11. GINSBERG HN, Reyes-Soffer G
    Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
    J Clin Invest. 2019 Aug 26. pii: 131333. doi: 10.1172/JCI131333.
    PubMed     Abstract available
    
    
    
12. RIECKMANN M, Delgobo M, Gaal C, Buchner L, et al
    Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses.
    J Clin Invest. 2019;130.
    PubMed     Abstract available
    
    
    July 2019
13. KANTER JE, Shao B, Kramer F, Barnhart S, et al
    Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.
    J Clin Invest. 2019;130.
    PubMed     Abstract available
    
    
    February 2019
14. LOWENSTEIN CJ, Bennett JA
    New vascular insights into premature aging.
    J Clin Invest. 2019;129:492-493.
    PubMed     Abstract available
    
    
    November 2018
15. OSMANAGIC-MYERS S, Kiss A, Manakanatas C, Hamza O, et al
    Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse.
    J Clin Invest. 2018 Nov 13. pii: 121297. doi: 10.1172/JCI121297.
    PubMed     Abstract available
    
    
    October 2018
16. LEE SJ, Lee CK, Kang S, Park I, et al
    Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.
    J Clin Invest. 2018 Oct 8. pii: 99659. doi: 10.1172/JCI99659.
    PubMed     Abstract available
    
    
    September 2018
17. HU C, Tian Y, Xu H, Pan B, et al
    Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury.
    J Clin Invest. 2018 Sep 11. pii: 98287. doi: 10.1172/JCI98287.
    PubMed     Abstract available
    
    
    July 2018
18. VIEIRA JM, Norman S, Villa Del Campo C, Cahill TJ, et al
    The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction.
    J Clin Invest. 2018 Jul 9. pii: 97192. doi: 10.1172/JCI97192.
    PubMed     Abstract available
    
    
    June 2018
19. THOSAR SS, Butler MP, Shea SA
    Role of the circadian system in cardiovascular disease.
    J Clin Invest. 2018;128:2157-2167.
    PubMed     Abstract available
    
    
    April 2018
20. EMMERSON A, Trevelin SC, Mongue-Din H, Becker PD, et al
    Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling.
    J Clin Invest. 2018 Apr 24. pii: 97490. doi: 10.1172/JCI97490.
    PubMed     Abstract available
    
    
    
21. ESCHENHAGEN T
    A new concept of fibroblast dynamics in post-myocardial infarction remodeling.
    J Clin Invest. 2018 Apr 16. pii: 121079. doi: 10.1172/JCI121079.
    PubMed     Abstract available
    
    
    
22. CHILDS BG, Li H, van Deursen JM
    Senescent cells: a therapeutic target for cardiovascular disease.
    J Clin Invest. 2018;128:1217-1228.
    PubMed     Abstract available
    
    
    February 2018
23. TAYLOR SI, Leslie BR
    Cardiovascular outcome trials of diabetes drugs: lessons learned.
    J Clin Invest. 2018 Feb 12. pii: 99820. doi: 10.1172/JCI99820.
    PubMed    
    
    
    August 2017
24. HE L, Huang X, Kanisicak O, Li Y, et al
    Preexisting endothelial cells mediate cardiac neovascularization after injury.
    J Clin Invest. 2017;127:2968-2981.
    PubMed     Abstract available
    
    
    June 2017
25. WATANABE R, Shirai T, Namkoong H, Zhang H, et al
    Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
    J Clin Invest. 2017;127:2725-2738.
    PubMed     Abstract available
    
    
    May 2017
26. FRANGOGIANNIS NG
    The extracellular matrix in myocardial injury, repair, and remodeling.
    J Clin Invest. 2017;127:1600-1612.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: